ENTITY
Astellas Pharma

Astellas Pharma (4503 JP)

134
Analysis
Health CareJapan
Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fields of Urology, Immunology including Transplantation and Infectious Diseases, Oncology, Neuroscience and DM Complications and Metabolic Diseases. With over 17,000 global employees, Astellas researches, develops, manufactures, and promotes its prescription drugs through subsidiaries in the US, Europe, and Asia
more
20 Aug 2016 01:02

JAPAN FLOW III:  The Mechanics of BOJ Buying

This is the latest in a series of JAPAN FLOW regarding recent and forward flow dynamics of Japan equities.The first two are:    JAPAN FLOW I:  The...

Logo
340 Views
Share
09 Aug 2016 18:52

A 'heads Up' on Changing World Heights

A comprehensive world survey of population heights over the last century has thrown up some surprising results. Americans have had the smallest...

Logo
Bixmoor
169 Views
Share
06 Aug 2016 18:07

Death Rattle for Defensives?

While it is not a given that a switch from a high growth, high interest rate environment to a low growth, low interest rate environment is a good...

bullishAstellas Pharma
02 Aug 2016 19:31

Implications for Astellas as Medivation Invites Offers

Medivation appears to have finally given up hope of remaining independent and has invited tenders to be made by mid-August, with Sanofi, Pfizer,...

01 Aug 2016 01:56

Korea Stock Market Monthly Recap #4 - (July 2016)

Key Events in July - Rebound from the Brexit announcement, driven by expectation of further delay in Fed's rate hikes coupled with increasing...

Logo
207 Views
Share
x